Menu
GeneBe

3-38560221-C-T

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate

The NM_001099404.2(SCN5A):c.4171G>A(p.Gly1391Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1391A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

SCN5A
NM_001099404.2 missense

Scores

5
5
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:9

Conservation

PhyloP100: 1.81
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a topological_domain Extracellular (size 51) in uniprot entity SCN5A_HUMAN there are 11 pathogenic changes around while only 1 benign (92%) in NM_001099404.2
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, SCN5A
PP3
MetaRNN computational evidence supports a deleterious effect, 0.845

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN5ANM_001099404.2 linkuse as main transcriptc.4171G>A p.Gly1391Arg missense_variant 23/28 ENST00000413689.6
SCN5ANM_000335.5 linkuse as main transcriptc.4168G>A p.Gly1390Arg missense_variant 23/28 ENST00000423572.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN5AENST00000413689.6 linkuse as main transcriptc.4171G>A p.Gly1391Arg missense_variant 23/285 NM_001099404.2 P4
SCN5AENST00000423572.7 linkuse as main transcriptc.4168G>A p.Gly1390Arg missense_variant 23/281 NM_000335.5 A1Q14524-2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152186
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000360
AC:
9
AN:
249826
Hom.:
0
AF XY:
0.0000443
AC XY:
6
AN XY:
135492
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000442
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000287
AC:
42
AN:
1461690
Hom.:
0
Cov.:
32
AF XY:
0.0000344
AC XY:
25
AN XY:
727126
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000288
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152186
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxAug 28, 2020In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30244407, 32569262, 31737537) -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 17, 2024This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1391 of the SCN5A protein (p.Gly1391Arg). This variant is present in population databases (rs780405533, gnomAD 0.006%). This missense change has been observed in individual(s) with long QT syndrome (PMID: 30244407, 31737537). ClinVar contains an entry for this variant (Variation ID: 201589). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiac arrhythmia Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthDec 15, 2023This missense variant replaces glycine with arginine at codon 1391 of the SCN5A protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with long QT syndrome and in her asymptomatic brother (PMID: 30244407) and in an individual suspected of being affected with long QT syndrome (PMID: 31737537). This variant has been identified in 9/249826 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthJan 03, 2024This missense variant replaces glycine with arginine at codon 1391 of the SCN5A protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with long QT syndrome and in her asymptomatic brother (PMID: 30244407) and in an individual suspected of being affected with long QT syndrome (PMID: 31737537). This variant has been identified in 9/249826 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1E;C1859062:Long QT syndrome 3;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterSep 21, 2022The c.4171G>A variant in SCN5A has previously been reported in individuals affected with long QT syndrome [PMID:30244407, 31737537] and in a related asymptomatic individual, both of which carried another variant in the KCNH2 [PMID:30244407]. The c.4171G>A variant has been deposited in ClinVar [ClinVar ID:201589] as a Variant of Uncertain Significance and is observed in 25 alleles (0.0031% minor allele frequency with 0 homozygotes) in population databases (gnomADv2.1.1 and v3.1.2, TOPMed Freeze 8, All of Us), suggesting it is not a common benign variant in the populations represented in those databases. The c.4171G>A variant in SCN5A is located in exon 23 of this 28-exon gene and predicted to replace an evolutionarily conserved glycine amino acid with arginine at position 1391 in the transmembrane DIII-repeat region of the protein [Uniprot, PMID:30364184]. In silico predictions are inconclusive of p. (Gly1391Arg) the variant's effect [(CADD v1.6 =36, REVEL = 0.633)]; however, there are no functional studies to support or refute these predictions. Variants nearby p.(Gly1391) residue within the DIII-repeat region have been reported in the literature [PMID: 20129283] and ClinVar [ClinVar ID: 9395] in individuals with Brugada syndrome. Based on available evidence this c.4171G>A p.(Gly1391Arg) variant identified in SCN5A is classified as a Variant of Uncertain Significance. -
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 09, 2022- -
Brugada syndrome Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingMolecular Genetics Laboratory, BC Children's and BC Women's HospitalsAug 14, 2019- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 16, 2020The p.G1391R variant (also known as c.4171G>A), located in coding exon 22 of the SCN5A gene, results from a G to A substitution at nucleotide position 4171. The glycine at codon 1391 is replaced by arginine, an amino acid with dissimilar properties. This alteration was detected in an individual with long QT syndrome as well as in her asymptomatic older brother, both of whom also carried the KCNH2 p.D803Y (c.2407G>T) (Szperl M et al. J. Appl. Genet., 2018 Nov;59:463-469). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Long QT syndrome 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsMay 04, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
CardioboostArm
Benign
0.0080
CardioboostCm
Benign
0.014
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.35
Cadd
Benign
23
Dann
Uncertain
1.0
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.24
FATHMM_MKL
Benign
0.42
N
M_CAP
Pathogenic
0.48
D
MetaRNN
Pathogenic
0.85
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-2.8
D;D;D;D;N;D;N;N;N
REVEL
Uncertain
0.63
Sift
Uncertain
0.025
D;D;D;D;T;D;D;T;T
Sift4G
Benign
0.26
T;T;T;T;T;T;T;T;T
Polyphen
0.99
D;D;.;D;.;P;D;.;.
Vest4
0.77
MutPred
0.64
Gain of loop (P = 0.069);.;Gain of loop (P = 0.069);Gain of loop (P = 0.069);.;Gain of loop (P = 0.069);.;.;.;
MVP
0.95
MPC
1.6
ClinPred
0.18
T
GERP RS
4.2
Varity_R
0.22
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs780405533; hg19: chr3-38601712; COSMIC: COSV61123164; API